Anactinomycete, strain C-38,383, was selected in a screening program for the isolation of novel antitumor agents. A yellow crystalline product, named rebeccamycin, was isolated from the mycelium and was found to have activity against P388 leukemia, L1210 leukemia and B16 melanoma implanted in mice. Rebeccamycin inhibits the growth of humanlung adenocarcinoma cells (A549) and produces single-strand breaks in the DNAof these cells. No DNA-protein cross-links were detected. A related antibiotic, staurosporine, is produced by Streptomyces staurosporeus and Streptomyces actuosus. Strain C-38,383 was found to resemble closely strains of Nocardia aerocolonigenes recently renamedSaccharothrix aerocolonigenes. A strain selection isolate without aerial mycelium, C-38,383-RK-l, failed to produce rebeccamycin while a strain with aerial mycelium, C-38,383-RK-2, was found to be a suitable strain for production. A description of the producing strain is presented and its taxonomic position is reviewed. A fermentor containing 37 liters of production medium gave a rebeccamycin yield of 663 mg/liter after 204 hours of incubation with strain C-38,383-RK-2.
Anactinomycete, strain C-38,383, was selected in a screening program for the isolation of novel antitumor agents. A yellow crystalline product, named rebeccamycin, was isolated from the mycelium and was found to have activity against P388 leukemia, L1210 leukemia and B16 melanoma implanted in mice. Rebeccamycin inhibits the growth of humanlung adenocarcinoma cells (A549) and produces single-strand breaks in the DNAof these cells. No DNA-protein cross-links were detected. A related antibiotic, staurosporine, is produced by Streptomyces staurosporeus and Streptomyces actuosus. Strain C-38,383 was found to resemble closely strains of Nocardia aerocolonigenes recently renamedSaccharothrix aerocolonigenes. A strain selection isolate without aerial mycelium, C-38,383-RK-l, failed to produce rebeccamycin while a strain with aerial mycelium, C-38,383-RK-2, was found to be a suitable strain for production. A description of the producing strain is presented and its taxonomic position is reviewed. A fermentor containing 37 liters of production medium gave a rebeccamycin yield of 663 mg/liter after 204 hours of incubation with strain C-38,383-RK-2.
Strain C-38,383, an actinomycete isolated from a soil sample collected in Panama, was selected for further study since clarified culture fluid inhibited KB cell culture growth.10 A product, crystallizing as fine yellow needles, was isolated from the mycelium of strain C-38,383 grown in submerged culture. This compound was found to be soluble in dimethyl sulfoxide and tetrahydrofuran, poorly soluble in commonlyused organic solvents and insoluble in water. Significant in vivo antitumor activity was obtained with murine tumor tests. The active compound,a novel iV-glycoside containing a symmetric heterocyclic aglycone with two chlorine atoms, was named rebeccamycin ( 
Materials and Methods
The procedures of Becker et alP and Yamaguchi8) were used for amino acid analysis of cellwall preparations. The sugar composition of whole-cell hydrolysates was determined with the procedures of Lechevalier and Lechevalier. 0) The methods of Minnikin et al.10 ) were used for detection of nocardomycolic acids in cell-wall preparations ; however, the thin-layer chromatographic system was changed to hexane -diethyl ether (80 : 20) . The determination of iV-acyl type of cell-wall glycan was performed as described by Uchida and Aida.10 Nocardia aerocolonigenes JCM4150, Nocardia asteroides CS-45 and Nocardia corallina NIHJ301 were included for comparison. Tests for utilization of carbon sources were done with Pridham-Gottlieb's inorganic medium.12) Observations were made after incubation at 37°C for 21 days.
Tests for inhibition of L1210 leukemia, P388 leukemia and B16 melanoma in mice were performed with procedures described previously.13~15) For biological testing rebeccamycin was dissolved in DMSO and stored at -20°C as 10 mMor 1 mg/ml aqueous solutions for no longer than 2 weeks. The effect of rebeccamycin on the viability of humanlung adenocarcinoma A549 cells16) was determined as described previously.17-* Briefly, 50,000 cells were added to 25 square-cm flasks and incubated at 37°C in McCoy's medium (Gibco Diagnostics 430-1500, Madison, Wisconsin, U.S.A.) for 24 hours, incubated with serial dilutions of the drug for 1 hour and then in the absence of drug for 5 days. At this time cells were suspended with trypsin -EDTA,treated with trypan blue and counted with a hemocytometer.
For measurement of inhibition of macromolecular biosynthesis A549 cells were harvested, washed in culture medium (37°C) and distributed as 1.0 ml aliquots of 1 x lO6 cells/ml in plastic test tubes. The cells were preincubated for 15 minutes at 37°C in the presence of different dilutions of drug then incubated for 2 hours after addition of 10 /^Ci of [ra£f/zy/-3H]thymidine to assess inhibition of DNA synthesis; for 1 hour after addition of 6.25 /*Ci of [5,6-3H] uridine and 20 jum unlabeled uridine to assess inhibition of RNA synthesis; and for 1 hour after addition of 6.25 i^Ci of [4,5-3H]leucine to assess inhibition of protein synthesis. The samples were adjusted to a final concentration of 10% TCA, cooled on ice and filtered through glass fibers (GF/A, Whatman). Tubes containing radioactive leucine were heated for 20 minutes at 70°C and placed in an ice bath for 1 hour. The filters were washed with 15 ml of 5 % TCA solution, dried and placed in scintillation fluid (Insta-Fluor, Packard) for radioactive counting.18)
Experimental cultures intended for alkaline elution were plated in 60 mmtissue culture dishes 3 days before the experiment and 0.01 //Ci/ml [14C]thymidine was added 48 hours prior to addition of the drug. Reference cells were also grown for 3 days in 75 cm2 flasks and labeled with 0.1^Ci/ml [3H]thymidine 2 days before the experiment. Cells containing 14C-DNAwere assayed for singlestrand break formation immediately following 1 hour incubation with drug in tissue culture medium with serum. The dishes were placed immediately on ice and the mediumwasexchangedfor trypsinEDTAto release the cells. The drug-treated cells (5 x 105) and y irradiated cells containing 3H-DNA added as an internal standard (5 X 105) were layered over polycarbonate filters (2.0 jam pores, 25 mm diameter from Nucleopore) and lysed in the presence of proteinase K and sodium dodecyl sulfate and the retained DNAwas slowly eluted at pH 12.1 as described by Kohn et al.19'20) Additional details of the procedure are provided elsewhere.21 >22)
The resulting 14C and 3H cpm of each eluted fraction were expressed as percents of total cpm obtained from the sum of the respective radioactivities in the filter, tubing, lysis and eluted fractions. Log percent values for 14C cpm of each eluted fraction were plotted against the log percent of 3H cpm of the same fraction and yielded elution curves that were linear with correlation coefficients >0.99 for controls and low concentration of drug. Slopes of elution curves from drug-treated cells were compared with slopes of elution curves from cells exposed to varying doses of ionizing radiation to obtain rad equivalents,19) which are related to DNAbreak frequencies by the equation: 1 rad equivalent=9 x 10" 10 single-strand DNAbreaks per nucleotide23) as previously described.2Ĉ ell lines of murine or human origin (Table 9) were maintained in continuous logarithmic culture in MEM(Eagle) with Earl's salts (Gibco Diagnostics 320-1090, Madison, Wisconsin, U.S.A.) Table 1 . Media for production of rebeccamycin. MAY 1987 Medium H34 Medium H95 Medium H96 Medium G134 Glucose (g/liter) Corn containing 2 him L-glutamine, benzylpenicillin (lO u/ml), streptomycin (10^g/ml), 3 mMMEMnonessential amino acids (100X, Gibco Diagnostics 320-1140) and 10% fetal bovine serum (enriched MEM). Cells were incubated at 37°C in a 5 % CO2, balance air, high humidity incubator. Cytotoxicity testing was performed as previously described24) with 48-hour continuous drug exposure. Cells were fixed with formalin (10%) in phosphate buffered saline for 10 minutes, air dried and stained with 0.09% crystal violet for 15 minutes. The stain was solubilized with 0.2 ml of 0.1 m AcOH-EtOH (1 : 1) and optical densities determined at 590 nm with a Dynatech MR600 microtiter plate reader. IC50 values were calculated by linear regression analysis of absorption data.
To obtain the antimicrobial spectrum of rebeccamycin Mueller-Hinton Agar (BBL) was used for tests with bacteria and Sabouraud Liquid Broth Modified (BBL) plus agar (10 g/liter) was used for tests with fungi.
The analysis of rebeccamycin in fermentation extracts was performed with HPLCon the RCM-100 (Waters Associates, Milford, MA, U.S.A.) system, including a radial pack silica cartridge (8 mm internal diameter x10 cm, 10 /^m packing). The solvent system was 2% MeOHin CHC13, the flow rate was 3 ml/minute and the detector wavelength was set at 313 nm.
Strain C-38,383 was grown in test tubes on agar slants of yeast -malt extract agar. This medium consisted of glucose 4.0 g, yeast extract 4.0 g, malt extract 10 g and agar 20 g in 1 liter distilled water. The culture was incubated for 7 days at 27°C. To prepare an inoculum for the production phase the surface growth from the slant culture was transferred to a 500-ml Erlenmeyer flask containing 100 ml of medium consisting of glucose 30 g, soy flour 10 g, cottonseed embryo meal 10 g and CaCO3 3 g in 1 liter distilled water. This vegetative culture was incubated at 27°C for 48 hours on a Gyrotory tier shaker (Model G53, New Brunswick Scientific Co., Inc., New Brunswick, N.J., U.S.A.) set at 210 rpm. Four ml of vegetative culture was transferred to a 500-ml Erlenmeyer flask containing 100 ml of production medium, some of which are listed in Table 1 . The production culture was incubated at 27°C on the same shaker. The agitation rate was 250 rpm. Nocardia aerocolonigenes OEU 701 (ATCC 23890) obtained from the American Type Culture Collection was included in flask fermentation studies. For production in a fermentor 2 liters of seed culture was transferred to 30 liters of production mediumG134 (Table 1 ). The incubation temperature was 27°C, the agitation rate was 375 rpm, the air flow was 60 liters/minute and the back pressure was 0.3 atm.
Results
Strain C-38,383 forms branching hyphae which develop into substrate mycelium and aerial mycelium (0.5 jam in width). These mycelia are long, well branched and do not fragment into filaments. Arthrospores, which are continuous chains or are intercallated with empty hyphae, are formed throughout the aerial mycelium. The aerial hyphae are divided into long segments which subdivide into spores of irregular size. Chains of intercalary or continuous spores are straight or flexuous. Some of these chains range in length from 50 to 100 spores and other chains are shorter in length. These spores are non-motile, have a smooth surface and are cylindrical in shape (0.5~0.7 x 0.7~5.0^m). Sclerotia are formed on the aerial mycelium but no sporangia or whorls are evident. Whenstrain C-38,383 is grown on agar media, colonies with and without aerial mycelium are evident. The formation of aerial mycelium is maintained when the culture is lyophilized and recovered.
The cell-wall of strain C-38,383 contains mera-diaminopimelic acid but lacks glycine. Wholecell hydrolysates show glucose, galactose, mannose and rhamnose. No nocardomycolic acids were observed with strain C-38,383 or Nocardia aerocolonigenes JCM 4150 and the iV-acyl type of cell-wall glycan was found to be acetyl. On the other hand, nocardomycolic acids were observed with Nocardia asteroides CS-45 and Nocardia corallina NIHJ301 and the JV-acyl type of cell-wall glycan was found to be glycolyl. Table 2 . The aerial mycelium, when fully developed, is light yellow. No melanin pigment is produced in peptone -yeast extract -iron agar, Tryptone -yeast extract agar or tyrosine agar. The optimal growth range is 28~37°C. There is moderate growth at 20°C and 41°C with no growth at 7°C or at 45°C. There is no growth on yeast extract -malt extract agar at pH 4.5 but there is growth at pH 5.0. Growth occurs with the medium containing 7%NaCl, but no growth is possible with 8%NaCl. Strain C-38,383 tolerates 0.01 % lysozyme in Trypticase soy broth plus 1.5% agar. Gelatin is liquefied, starch is hydrolyzed and nitrate is reduced. In Difco skimmedmilk mediumthere is peptonization without coagulation. A comparison of strain C-38,383 with published data25) on strains of N. aerocolonigenes and Nocardiopsis dassonvillei is given in Table 3 .
Prolongation of survival of leukemic mice was observed at dose levels ranging from 8 to 256 mg/kg with P388 leukemia (Table 4 ) and LI210 leukemia (Table 5 ). The effect of this drug on B16 melanoma is given in Table 6 . At a concentration of 6.0 /^g/ml rebeccamycin gave a 50% inhibition (IC50) of human lung adenocarcinoma cells (Fig. 2) . In the same test procedure etoposide (VP-16-213), teni- Effect: %T/C-(MST treated/MST control) x 100. Criteria: % T/C >125 considered significant antitumor activity.
poside (VM-26) and mitomycin C gave IC50 values of 2.6, 0.5 and 0.2 A*g/ml, respectively. In Table  7 data on the inhibition of macromolecular biosynthesis are presented. At 100^g/ml rebeccamycin had limited effect on RNAand protein synthesis. On the other hand there was a 43% inhibition ofDNA synthesis at 100^g/ml. Fig. 3 presents typical alkaline elution curves resulting 673 Effect: % T/C-(MST treated/MST control) x 100. Criteria: % T/C >125 considered significant antitumor activity. Effect: % T/C-(MST treated/MST control) x 100. Criteria: %T/C >140 considered significant antitumor activity.
from 1 hour exposure of cells to increasing concentrations of rebeccamycin. DNAbreakage was observed at 0.15~5.0 jug/ml. The elution curve for 0.5^g/ml is almost linear. In Table 8 rebeccamycin shows an accelerated rate of DNAbreakage with increasing concentration. Rebeccamycin, mitomycin C and cisplatin gave a positive response in the microtiter mammaliancell adhesion test (Table 9 ). The antimicrobial spectrum of rebeccamycin (Table 10) indicates that Staphylococcus aureus is sensitive at 1^g/ml and Streptococcus faecalis is sensitive at 8 /^g/ml.
Onagar media strain C-38,383 gave rise to colonies with and without aerial mycelium. Strain RK-1 without aerial mycelium and strain RK-2 with aerial mycelium were selected and tested for production of rebeccamycin. Strain RK-1 failed to produce detectible levels of antibiotic in 3 media (<0.05 mg/liter) while strain RK-2 gave 27.1 mg/liter in medium H34, 71.3 mg/liter in medium H95 and 160.8 mg/liter in medium H96 (Table 1) after 168 hours of incubation.
N. aerocolonigenes drug for 1 hour in dishes. Lysed cells on polycarbonate filters were treated with proteinase K and the eluted 14C radioactivity was plotted against the elution of 3H-DNAfrom added internal standard cells irradiated with 300 rads.
à" No rebeccamycin, O 0.05^g/ml, H 0.15 /Wg/ml, å¡ 0.5^g/ml, A 1.5 /ig/ml and a 5.0^g/ml. OEU701 (ATCC23870) has no aerial mycelium and failed to produce rebeccamycin in fermentation trials. In a fermentor with 30 liters of an improved production medium G134 (Table 1) , the yield at 204 hours was 663 mg/liter. A successful tank fermentation with 3,000 liters was completed for the isolation of rebeccamycin in sufficient yield for chemical studies and biological evaluation.
Discussion
Strain C-38,383 was compared with ten genera of Order Actinomycetales, including Nocardia, A ctinopolyspora, Micropolyspora, Nocardiopsis, Saccharomonospora, Saccharopolyspora, Pseudonocardia, Actinosynnema, Streptoalloteichus and Saccharothnx26) all of which produce spore chains on aerial mycelium and contain m&so-diaminopimelic acid in the cell-wall. Strains in the genus Nocardiopsis are similar to strain C-38,383 with regard to spore-chain and spore morphology, but differ from strain C-38,383 in lacking galactose and mannose in the whole-cell sugar pattern. As seen in Table 2 , strain C-38,383 shows more similarity to Nocardia aerocolonigenes (Shinobu and Kawato) Pridham27~29) than Nocardiopsis dassonvillei.á">zl) Gordon et al.25) reported that 8 of 14 strains of Nocardia aerocolonigenes formed aerial mycelium on initial examination but lost the ability to form aerial mycelium on continued transfer. Only 1 of the 14 strains formed aerial mycelium with conidia. The cell-wall of these 14 strains contain galactose but no arabinose. Four strains were reported to contain madurose and all were reported to be non-acid fast when grown on glycerol agar.25»32) This pattern of cell-wall and whole-cell components which includes raew-diaminopimelic acid, galactose with no arabinose or madurose is type IIIC.95 While the sporulation of strain C-38,383 resembles N. dassonvillei, strain C-38,383 resembles closely strains of the atypical Nocardia species, N. aerocolonigenes.
All strains of JV. aerocolonigenes including strain C-38,383 lack mycolic acids and strains IMRU 983, IMRU1663 and IMRU1432 were found to be resistant to phages from Nocardia strains with mycolic acids.33'34) Pridham and Lyons28) reported that traces of arabinose were present in wholecell hydrolysates of the type strain of N. aerocolonigenes strain OEU701, ISP 5034, ATCC23870. Good fellow and Cross35) accordingly considered that taxon to have cell-wall type IV and they proposed to place strains designated N. aerocolonigenes in the group with the epithet 'Micropolysporas' along with Actinopolyspora, Pseudonocardia, Saccharomonospora and Saccharopolyspora. Recently, Labeda proposed the placement of "Nocardia aerocolonigenes" in the genus Saccharothrix as Saccharothrix aerocolonigenes.,36) The chemotaxonomic properties characteristic of the genus Saccharothrix are such that whole-cell hydrolysates contain the mesoisomer of diaminopimelic acid. Rhamnoseand galactose are the characteristic sugars and mycolic acids are absent.
It is expected that continued study of non-Streptomyces sporogenic actinomycetes will results in additional changes in classification of these diverse strains. For the present time, strain C-38,383 is considered to be a member of the species Saccharothrix aerocolonigenes. Strain C-38,383-RK-2 has been deposited with the American Type Culture Collection as ATCC39243. This organism gives rise to mutants without aerial mycelium. If production of aerial mycelium is to be maintained, serial passage of the culture should be kept to a minimum.
Evidence has been presented showing that rebeccamycin introduces breaks in eukaryotic DNA. These breaks appear to be random since rebeccamycin at 0.5 //g/ml gave an approximately linear elution curve. It is possible that the planar ring structure mayfavor intercalation into DNAcomparable to 4'-(9-acridinylamino)methanesulfon-ra-anisidide (m-AMSA), doxorubicin and ellipticine.370 Recent evidence suggests that some DNA-intercalating drugs produce DNAbreakage by a direct or indirect action upon Type II topoisomerase.38»39) However, recent studies utilizing alkaline elution techniques have failed to demonstrate the presence of either DNA-protein cross-links or double-strand DNA breaks following exposure of A549 cells to rebeccamycin (B. H. Long, unpublished results). These results argue against a mechanism of action involving either direct or indirect involvement of type II topoisomerase, but do not exclude free radical or alkylation mechanisms. Further studies are being conducted to explore these possibilities.
The level of rebeccamycin required to give 43 % inhibition of DNAsynthesis is over 16-fold higher than the concentration needed to give a 50% inhibition of cell growth (6.0^g/ml). Most likely the primary effect of rebeccamycin is extensive fragmentation of DNAfrom high doses of the drug rather than inhibition of DNAsynthesis. In the microtiter mammalian cell adhesion test A549, B16-F10 and HCT-116cell lines are more sensitive that KB, Moser and Ml09 cell lines while cisplatin and mitomycin C do not show such differential effects. Other studies have shownthe usefulness of the microtiter test for the evaluation of anticancer compounds.40»41) Rebeccamycin has a limited antimicrobial spectrum which shows inhibition of Staphylococcus aureus at 1^g/ml and Streptococcus faecalis at 8^g/rrd. The related antibiotic staurosporine is not active against these organisms at 200^g/ml. Staurosporine is active against yeasts and filamentous fungi6) while rebeccamycin is inactive at 32^g/ml. The cytotoxicity of staurosporine and its ability to induce differentiation in human neuroblastoma cells (NB-1) is noteworthy.
Rebeccamycin has a structure different from the drugs used thus far for clinical anticancer therapy. There is a broad therapeutic range with rodent tumor models and promising effects with humanlung adenocarcinoma cells have been observed. Therefore, rebeccamycin is considered a possible candidate for further development toward clinical trial.
